ScoreWhy is Balaxi Pharmaceuticals Ltd ?
1
Weak Long Term Fundamental Strength with a -26.26% CAGR growth in Operating Profits
2
Flat results in Jun 26
- PAT(Latest six months) At Rs 1.91 cr has Grown at -78.61%
- CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 14.56 cr
3
With ROE of 0.6, it has a Very Expensive valuation with a 0.5 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -100.00%, its profits have fallen by -87.1%
4
Below par performance in long term as well as near term
- Along with generating -100.00% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Balaxi Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Balaxi Pharma
-44.58%
-0.95
46.49%
Sensex
-1.65%
-0.12
13.58%
Management Risk
Growth
Capital StructureValuationValuation Key Factors 
Factor
Value
P/E Ratio
55
Industry P/E
Price to Book Value
0.54
EV to EBIT
27.29
EV to EBITDA
19.62
EV to Capital Employed
0.61
EV to Sales
0.63
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.18%
ROE (Latest)
0.57%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET SALES(Q)
Highest at Rs 80.68 cr
PBDIT(Q)
Highest at Rs 4.66 cr.
PBT LESS OI(Q)
Highest at Rs 3.08 cr.
PAT(Q)
Highest at Rs 1.30 cr.
EPS(Q)
Highest at Rs 0.24
-9What is not working for the Company
PAT(Latest six months)
At Rs 1.91 cr has Grown at -78.61%
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 14.56 cr
Loading Valuation Snapshot...
Here's what is working for Balaxi Pharma
Profit After Tax (PAT) - Quarterly
At Rs 1.30 cr has Grown at 348.3%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 80.68 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 4.66 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 3.08 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 1.30 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 0.24
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Balaxi Pharma
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 14.56 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
